1. Home
  2. HROW vs VRRM Comparison

HROW vs VRRM Comparison

Compare HROW & VRRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HROW

Harrow Inc.

HOLD

Current Price

$37.85

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Verra Mobility Corporation

VRRM

Verra Mobility Corporation

HOLD

Current Price

$3.91

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
VRRM
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
HROW
VRRM
Price
$37.85
$3.91
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$69.86
$25.90
AVG Volume (30 Days)
538.3K
3.0M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
347.37
EPS
N/A
N/A
Revenue
N/A
$132,969,000.00
Revenue This Year
$31.62
$6.84
Revenue Next Year
$50.77
$6.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.61
52 Week Low
$28.54
$3.40
52 Week High
$54.98
$25.45

Technical Indicators

Market Signals
Indicator
HROW
VRRM
Relative Strength Index (RSI) 42.89 29.62
Support Level $37.00 $3.40
Resistance Level $42.40 $4.75
Average True Range (ATR) 1.70 0.17
MACD -0.14 -0.05
Stochastic Oscillator 20.74 0.00

Price Performance

Historical Comparison
HROW
VRRM

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About VRRM Verra Mobility Corporation

Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.

Share on Social Networks: